Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects
A phase 2 trial of Electrochemotherapy in Breast cancer, run by Copenhagen University Hospital at Herlev, recorded as terminated on the registry.
Overview
Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects is a phase 2 interventional study registered as NCT00744653 by Copenhagen University Hospital at Herlev, with 17 participants recorded, started 2008-10 and due to reach its primary completion in 2010-11. Interventions recorded: Electrochemotherapy. Conditions recorded: Breast Cancer.
Linked to the technology Electrochemotherapy because the registry names it ("electrochemotherapy") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialElectrochemotherapy for Recurrent Vulvar Cancer
Shares Electrochemotherapy and the tag pipeline.
- TrialElectrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer
Shares Electrochemotherapy and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- Trial[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma
Shares Breast cancer (all types) and the tag pipeline.